The therapeutic equivalence of oral and intravenous iron in renal dialysis patients.
Oral and intravenous iron were compared in patients treated with renal dialysis by a cross-over trial. Intravenous iron was given over 2 weeks as an iron dextran (equivalent to 100 mg elemental iron). Oral iron was given daily as ferrous sulphate (equivalent to 100 mg elemental iron) in a wax matrix tablet. Each treatment period lasted 26 weeks. There was no significant difference in therapeutic or unwanted effects between the treatments.
D000284:Administration, Oral; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D002986:Clinical Trials as Topic; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007275:Injections, Intravenous; D007501:Iron / Q000008:administration & dosage*; D008297:Male; D006435:Renal Dialysis; D013810:Therapeutic Equivalency; D014168:Transferrin / Q000032:analysis
D006454:Hemoglobins; D014168:Transferrin; D007501:Iron